INMD
Get informed when a big investor buys or sells
+ FollowUndervalued by 148.8% based on the discounted cash flow analysis.
| Market cap | $865.66 Million |
|---|---|
| Enterprise Value | $489.39 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.45 |
| Beta | 1.87 |
| Outstanding Shares | 58,903,000 |
| P/E Ratio | 12.05 |
|---|---|
| PEG | -33.29 |
| Price to Sales | 2.5 |
| Price to Book Ratio | 1.5 |
| Enterprise Value to Revenue | 1.31 |
| Enterprise Value to EBIT | 6.18 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.03 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 2.1573▲ 10.04% |
|---|---|
| Total Calls | 455,900▲ 24.05% |
| Total Puts | 983,500▲ 30.11% |
Holdings and activity of institutional investors.
| Ownership % | 49.55%▼ 2.32% |
|---|---|
| Total Invested | $698.99M▲ 52.46% |
| Investors Holding | 201▼ 1.00% |
No data
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ('RF') technology. InMode strives to enable new emerging surgical procedures as we...